Michael Petusky

Stock Analyst at Barrington Research

(3.39)
# 1,034
Out of 4,479 analysts
102
Total ratings
47.92%
Success rate
2.5%
Average return

14 Stocks

Surmodics
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $41.97
Upside: -
VerifyMe
May 24, 2024
Maintains: Outperform
Price Target: $2$1.7
Current: $1.32
Upside: +28.79%
Haemonetics
May 10, 2024
Maintains: Outperform
Price Target: $105$107
Current: $83.12
Upside: +28.73%
Anika Therapeutics
May 9, 2024
Maintains: Outperform
Price Target: $37
Current: $25.90
Upside: +42.86%
U.S. Physical Therapy
May 9, 2024
Maintains: Outperform
Price Target: $122
Current: $92.27
Upside: +32.22%
Henry Schein
May 8, 2024
Maintains: Outperform
Price Target: $90$92
Current: $65.67
Upside: +40.09%
LeMaitre Vascular
May 3, 2024
Maintains: Outperform
Price Target: $69$79
Current: $81.09
Upside: -2.58%
DENTSPLY SIRONA
May 3, 2024
Maintains: Outperform
Price Target: $41$38
Current: $24.62
Upside: +54.38%
Merit Medical Systems
May 1, 2024
Maintains: Outperform
Price Target: $98$100
Current: $86.89
Upside: +15.09%
Option Care Health
Apr 24, 2024
Maintains: Outperform
Price Target: $38
Current: $27.60
Upside: +37.71%
OPKO Health
Apr 1, 2024
Maintains: Outperform
Price Target: $1.5
Current: $1.22
Upside: +23.46%
ModivCare
Feb 26, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $27.33
Upside: -
Lifecore Biomedical
Sep 1, 2023
Maintains: Outperform
Price Target: $11$10
Current: $4.59
Upside: +118.10%
ATI Physical Therapy
Jul 27, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.89
Upside: -